Summary of a clinical trial with liposome-adjuvanted influenza A virus vaccine in elderly adults

Mechanisms of Ageing and Development

Volumn 93, Issue 1-3, 1997, Pages 179-188

  Powers, Douglas C ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Antibodies; Cytotoxic T lymphocytes; Elderly; Influenza; Liposome; Vaccine

Indexed keywords

ANTIBODY; INFLUENZA VACCINE; LIPOSOME;

AGED; ANTIBODY TITER; CELL ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIARRHEA; DOUBLE BLIND PROCEDURE; EDEMA; ERYTHEMA; FEVER; HEADACHE; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALAISE; MUSCLE STIFFNESS; MYALGIA; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; VOMITING;

ADJUVANTS, IMMUNOLOGIC; AGED; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CYTOTOXICITY, IMMUNOLOGIC; DOUBLE-BLIND METHOD; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIPOSOMES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030887978     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(96)01809-X     Document Type: Conference Paper

References (23)

1. Immunization Practices Advisory Committee, Prevention and control of influenza. Morbid. Mortal. Wkly. Rep., 45 (1996) 1-24.
2. P.A. Gross, A.W. Hermogenes, H.S. Sacks, J. Lau and R.A. Levandowski, The efficacy of influenza vaccine in elderly persons. Ann. Intern. Med., 123 (1995) 518-527.
3. D.J. D'Alessio, P.M. Cox Jr. and E.D. Dick, Failure of inactivated influenza vaccine to protect an aged population. JAMA, 210 (1969) 485-489.
4. B.J. Feery, M.G. Evered and E. Morrison, Different protection rates in various groups of volunteers given subunit influenza virus vaccine in 1976. J. Infect. Dis., 139 (1979) 237-241.
5. N.H. Arden, P.A. Patriarca, M.B. Fasano et al., The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch. Intern. Med., 148 (1988) 865-868.
6. M.L. Cartter, P.O. Renzullo, S.D. Helgerson, S.M. Martin and J.F. Jekel, Influenza outbreaks in nursing homes: how effective is influenza vaccine in the institutionalized elderly? Infect. Control Hosp. Epidemiol., 11 (1990) 473-478.
7. D.C. Powers, Influenza vaccination strategies in the elderly. Aging Immunol. Infect. Dis., 5 (1994) 47-54.
8. G. Gregoriadis, Immunological adjuvants: a role for liposomes. Immunol. Today, 11 (1990) 89-97.
9. R. Reddy, F. Zhou, S. Nair, L. Huang and B.T. Rouse, In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes. J. Immunol., 148 (1992) 1585-1589.
10. D.S. Collins, K. Findlay and C.V. Harding, Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. J. Immunol., 148 (1992) 3336-3341.
11. D.C. Powers, P.J. Hanscome and P.J.F. Pietrobon, In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant. Vaccine, 13 (1995) 1330-1335.
12. A.P. Kendal and W. R. Dowdle, Influenza virus. In N.R. Rose, H. Friedman and J.L. Fahey (eds.), Manual of Clinical Laboratory Immunology, 3rd edn, American Society for Microbiology, Washington, D.C., 1986, pp. 515-520.
13. D.C. Powers and R.B. Belshe, Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine. J. Infect. Dis., 167 (1993) 584-592.
14. D.C. Powers, Increased immunogenicity of inactivated influenza virus vaccine containing purified surface antigen compared with whole virus in elderly women. Clin. Diagn. Lab. Immunol., 1 (1994) 16-20.
15. D.C. Powers, M.C. Manning, P.J. Hanscome and P.J.F. Pietrobon, Cytotoxic T lymphocyte responses to a liposome-adjuvanted influenza A virus vaccine in elderly adults. J. Infect. Dis., 172 (1995) 1103-1107.
16. T.R. Cate, W.A. Keitel, J.M. Quarles, P.J.F. Pietrobon and R.B. Couch, Effects of parenteral, liposomal influenza vaccine in healthy adults. (Abstract 220) In Program and Abstracts of the 32nd Annual Meeting of IDSA, Orlando, FL, 1994, p. 38A.
17. G.L. Ada and P.D. Jones, The immune response to influenza infection. Curr. Top. Microbiol. Immunol., 128 (1986) 1-54.
18. A. McMichael, Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol., 189 (1994) 75-91.
19. G.F. Rimmelzwaan and A.D.M.E. Osterhaus, Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? Vaccine, 13 (1995) 703-705.
20. A.J. McMichael, F.M. Gotch, G.R. Noble and P.A.S. Beare, Cytotoxic T-cell immunity to influenza. N. Engl. J. Med., 309 (1983) 13-17.
21. C.M. Lawson, J.R. Bennink, N.P. Restifo, J.W. Yewdell and B.R. Murphy, Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge. J. Virol., 68 (1994) 3505-3511.
22. B.S. Bender, W.E. Bell, S. Taylor and P.A. Small Jr., Class I major histocompatibility complex-restricted cytotoxic T lymphocytes are not necessary for heterotypic immunity to influenza. J. Infect. Dis., 170 (1994) 1195-1200.
23. G. Palladino, K. Mozdzanowska, G. Washko and W. Gerhard, Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol., 69 (1995) 2075-2081.